US Stock MarketDetailed Quotes

VERV Verve Therapeutics

Watchlist
  • 6.310
  • -0.140-2.17%
Close Feb 26 16:00 ET
  • 6.350
  • +0.040+0.63%
Post 20:01 ET
534.23MMarket Cap-2.57P/E (TTM)

About Verve Therapeutics Company

Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Burt A. Adelman, Keith J. Joung, Sekar Kathiresan, Kiran Musunuru, Anthony Philippakis, Issi Rozen, and Barry Ticho in 2018 and is headquartered in Boston, MA.

Company Profile

SymbolVERV
Company NameVerve Therapeutics
Listing DateJun 17, 2021
Issue Price19.00
Founded2018
CEODr. Sekar Kathiresan, M.D.
MarketNASDAQ
Employees255
Fiscal Year Ends12-31
Address201 Brookline Avenue,Suite 601
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02215
Phone1-617-603-0070

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Sekar Kathiresan, M.D.
  • Chief Executive Officer and Director
  • 9.32M
  • Allison Dorval
  • Chief Financial Officer and Principal Accounting Officer
  • 3.48M
  • Dr. Ourania Tatsis, PhD
  • Director; Executive Vice President and Chief Regulatory and Quality Officer of Vertex Pharmaceuticals
  • --
  • Frederick Fiedorek, M.D.
  • Chief Medical Officer
  • --
  • Andrew D. Ashe, J.D.
  • President and Chief Operating Officer
  • --
  • Troy Lister, PhD
  • Chief Scientific Officer
  • --
  • Joan Nickerson
  • Chief Administrative Officer
  • --
  • Dr. Burt A. Adelman, M.D.
  • Chairman of the Board
  • 451.88K
  • Sheila Mikhail, J.D.
  • Independent Director
  • 412.38K
  • Alexander G. Cumbo
  • Independent Director
  • 405.88K
  • Dr. Krishna Yeshwant, M.D.
  • Independent Director
  • 410.88K
  • Jodie P. Morrison
  • Independent Director
  • --
  • Michael F. Maclean
  • Independent Director
  • 521.07K
  • Lonnel Coats
  • Independent Director
  • 407.38K